1st June 2007
New York State Department of Health
Summary,

Source: National Guidelines Clearinghouse

GUIDELINE OBJECTIVE(S)

To provide recommendations for prevention and management of dyslipidemia in human immunodeficiency virus (HIV)-infected patients

TARGET POPULATION

Human immunodeficiency virus (HIV)-infected patients

INTERVENTIONS AND PRACTICES CONSIDERED

Diagnosis/Assessment/Prevention

1. Assessment of cardiovascular risk factors
2. Obtaining a fasting lipid profile including total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides

Management/Treatment/Prevention

1. Lifestyle modification including smoking cessation, exercise, weight loss, substance use treatment if indicated
2. Pharmacologic treatment (e.g., statins)
3. Regular lipid profile monitoring in patients receiving antiretroviral therapy

MAJOR OUTCOMES CONSIDERED

Not stated